# Effects of Brain Beta-Amyloid on Postoperative Cognition

> **NCT01606488** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 66 (actual)

## Conditions studied

- Postoperative Cognitive Dysfunction

## Interventions

- **DRUG:** Florbetapir F 18 (18F-AV-45)
- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT01606488
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-05
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01606488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01606488, "Effects of Brain Beta-Amyloid on Postoperative Cognition". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01606488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*